Selpercatinib efficacy and safety in patients with RET-altered thyroid cancer: A clinical trial update Meeting Abstract


Authors: Sherman, E. J.; Wirth, L. J.; Shah, M. H.; Cabanillas, M. E.; Robinson, B.; Laskin, J. J.; Kroiss, M.; Subbiah, V.; Drilon, A. E.; Wright, J.; Soldatenkova, V.; French, P. P.; Italiano, A.; Weiler, D.
Abstract Title: Selpercatinib efficacy and safety in patients with RET-altered thyroid cancer: A clinical trial update
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120603264
DOI: 10.1200/JCO.2021.39.15_suppl.6073
PROVIDER: wos
Notes: Meeting Abstract: 6073 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eric J Sherman
    339 Sherman
  2. Alexander Edward Drilon
    632 Drilon